Growing community of inventors

St Etienne de Crossey, France

Emmanuelle Soleilhac

Average Co-Inventor Count = 7.20

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Emmanuelle SoleilhacCaroline Barette (2 patents)Emmanuelle SoleilhacCatherine Pillet (2 patents)Emmanuelle SoleilhacClaude Cochet (1 patent)Emmanuelle SoleilhacOdile Filhol (1 patent)Emmanuelle SoleilhacMagda Mortier (1 patent)Emmanuelle SoleilhacPatrice Vanelle (1 patent)Emmanuelle SoleilhacCarmen Aguilar (1 patent)Emmanuelle SoleilhacSofia Giacosa (1 patent)Emmanuelle SoleilhacVincent Remusat (1 patent)Emmanuelle SoleilhacMarie-Odile Fauvarque (1 patent)Emmanuelle SoleilhacThierry Terme (1 patent)Emmanuelle SoleilhacVincent Remusat (0 patent)Emmanuelle SoleilhacPatrice Vanelle (0 patent)Emmanuelle SoleilhacEmmanuelle Soleilhac (2 patents)Caroline BaretteCaroline Barette (5 patents)Catherine PilletCatherine Pillet (2 patents)Claude CochetClaude Cochet (5 patents)Odile FilholOdile Filhol (2 patents)Magda MortierMagda Mortier (1 patent)Patrice VanellePatrice Vanelle (1 patent)Carmen AguilarCarmen Aguilar (1 patent)Sofia GiacosaSofia Giacosa (1 patent)Vincent RemusatVincent Remusat (1 patent)Marie-Odile FauvarqueMarie-Odile Fauvarque (1 patent)Thierry TermeThierry Terme (1 patent)Vincent RemusatVincent Remusat (0 patent)Patrice VanellePatrice Vanelle (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives (2 from 4,872 patents)

2. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)

3. Université´ D'aix-Marseille (1 from 229 patents)

4. Université Grenoble Alpes (1 from 152 patents)


2 patents:

1. 11306063 - Heterocyclic naphthoquinones derivatives for use in the treatment of cancers including Cushing disease

2. 10322133 - Synthetic lethal drug combination for treating renal cell carcinoma

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…